Curis (CRIS) Change in Acquisitions & Divestments (2010 - 2024)
Curis (CRIS) reported Change in Acquisitions & Divestments of -$428000.0 for Q4 2024, down 102.12% on a YoY basis from $20.2 million in Q1 2024, and down 102.34% quarter-over-quarter from $18.3 million in Q3 2024.
Curis (CRIS) Change in Acquisitions & Divestments (2010 - 2024) Analysis & Trends
Curis has reported Change in Acquisitions & Divestments for 15 years, with the latest figure at -$428000.0 in Q4 2024.
- For the quarter ending Q4 2024, Change in Acquisitions & Divestments fell 102.12% year-over-year to -$428000.0; the trailing twelve-month figure through Sep 2025 stood at -$428000.0 (down 100.63% YoY), and the FY2024 full-year result was $47.5 million, down 56.03% from the prior year.
- Change in Acquisitions & Divestments for Q4 2024 stood at -$428000.0, down from $18.3 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $43.9 million in Q1 2023, with the low at -$428000.0 in Q4 2024.
- Historically, Change in Acquisitions & Divestments has averaged $17.7 million across 5 years, with a median of $18.0 million in 2022.
- Annual changes were most pronounced in 2021 — Change in Acquisitions & Divestments surged 112600.0% — and 2024, when it tumbled 102.12%.
- Curis' Change in Acquisitions & Divestments stood at -$4000.0 in 2020, then jumped by 465725.0% to $18.6 million in 2021, then slipped by 13.86% to $16.0 million in 2022, then gained by 25.91% to $20.2 million in 2023, then plunged by 102.12% to -$428000.0 in 2024.
- The last three Change in Acquisitions & Divestments figures came in at -$428000.0 (Q4 2024), $18.3 million (Q3 2024), and $29.6 million (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -428,000.00 |
| Dec 31, 2024 | -428,000.00 |
| Sep 30, 2024 | 18.32 Mn |
| Sep 30, 2024 | 18.32 Mn |
| Mar 31, 2024 | 29.65 Mn |
| Mar 31, 2024 | 29.65 Mn |
| Dec 31, 2023 | 20.20 Mn |
| Dec 31, 2023 | 20.20 Mn |
| Sep 30, 2023 | 36.50 Mn |
| Sep 30, 2023 | 36.50 Mn |
| Jun 30, 2023 | 7.50 Mn |
| Jun 30, 2023 | 7.50 Mn |
| Mar 31, 2023 | 43.93 Mn |
| Mar 31, 2023 | 43.93 Mn |
| Dec 31, 2022 | 16.04 Mn |
| Dec 31, 2022 | 16.04 Mn |
| Sep 30, 2022 | 18.00 Mn |
| Sep 30, 2022 | 18.00 Mn |
| Jun 30, 2022 | 39.50 Mn |
| Jun 30, 2022 | 39.50 Mn |